Polypharmacy in Adults With Systemic Lupus Erythematosus
Our results underscore the need to address the burden of medication regimens in this population through individualized medication optimization strategies that account for prescription and OTC medications used by those with SLE.
Authors
- Charmayne Dunlop‐Thomas
- Matthew E. Growdon (ORCID: https://orcid.org/0000-0001-5997-4406)
- Sung Sam Lim (ORCID: https://orcid.org/0000-0003-2361-0787)
- Jinoos Yazdany (ORCID: https://orcid.org/0000-0002-3508-4094)
- Kenneth E. Covinsky
- Laura Plantinga (ORCID: https://orcid.org/0000-0003-0809-8981)
- C. Barrett Bowling (ORCID: https://orcid.org/0000-0001-6265-8623)
- Courtney Hoge (ORCID: https://orcid.org/0000-0001-5500-3709)
- Jessica Fitzpatrick (ORCID: https://orcid.org/0000-0002-2686-7628)
- Jianing Yang
Institutions
- Emory University (US)
- Duke University (US)
- University of California, San Francisco (US)
- Alameda Health System (US)
- Geriatric Research Education and Clinical Center (US)
- Durham VA Health Care System (US)
- Durham VA Medical Center (US)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1002/acr.25686
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- Centers for Disease Control and Prevention